This site is intended for healthcare professionals
Micrograph of bone marrow rendered in pinks and purples

Find disease awareness content and relevant supporting materials

    Learning Zone CME Events News Trials Guidelines Journals
    Filter results
    Sort by:
    Relevance
    to
    Guidelines
    Guideline
    13/11/13

    EPA Guidance on tobacco dependence and strategies for smoking cessation in people with mental illness

    This statement from the European Psychiatric Association (EPA) systematically reviews the current evidence on tobacco dependence and withdrawal in patients with mental illness and their treatment.

    • Source: European Psychiatric Association (EPA)
    Journals
    Journal
    10/11/17

    Cost of illness of atrial fibrillation: a nationwide study of societal impact.

    Background: The prevalence of atrial fibrillation is increasing rapidly; however, to date, population-based data are lacking on the attributable cost of illness of atrial fibrillation from a societal perspective, including both...

    • Source: BMC Health Services Research
    Journals
    Journal
    30/06/19

    Primary care of asthma: new options for severe eosinophilic asthma.

    This paper reviews asthma assessment in primary care and describes the pathophysiology, clinical characteristics and new targeted treatments available for patients with severe eosinophilic asthma.

    • Source: Current Medical Research and Opinion
    Journals
    Journal
    26/04/17

    The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.

    Background: Asthma exacerbations are frequent in patients with severe disease. This report describes results from two retrospective cohort studies describing exacerbation frequency and risk, emergency department (ED)/hospital re-admissions, and asthma-related costs by asthma severity in the US and UK.

    • Source: BMC Pulmonary Medicine
    A smaller hand holds a larger hand in hospital
    Advocacy news
    21/02/18

    The BMJ debates assisted dying, urging the BMA to change their stance

    A series of articles published recently by The BMJ explore this issue, examining the social, legal and ethical considerations that have to be made before assisted dying can be brought into law.
    Journals
    Journal
    15/01/21

    Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

    This study evaluates the efficacy and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid asthma. It shows significant improvements in both upper and lower airway disease control and health-related quality of life (HRQoL).

    • Source: Annals of Allergy, Asthma & Immunology
    Journals
    Journal
    12/09/19

    Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden.

    Background and Objective: Despite improved asthma and chronic obstructive pulmonary disease (COPD) management, treatment remains inadequate in many patients. Understanding the impact of current treatment in settings outside of controlled trials would add important clinical decision-making information.

    • Source: European Clinical Respiratory Journal
    Clinician-patient relationship
    Spotlight
    06/05/25

    The clinician-patient relationship, online and offline: An opportunity to contribute to improved population health outcomes

    The importance of the clinician-patient relationship remains, despite its transcendence into online spaces.

    • Source: Daisy De Windt, BBus, BSc in BiomedSc
    Journals
    Journal
    07/10/19

    Efficacy of bronchial thermoplasty in patients with severe asthma.

    Objective: To investigate the efficacy and safety of bronchial thermoplasty (BT) in clinical practice in adults with severe, refractory asthma.

    • Source: Journal of Asthma
    Blue test tubes arranged in a line, disappearing into the background
    Drug news
    02/10/19

    Nucala significantly reduces exacerbations in first global prospective real-world study of a biologic in severe eosinophilic asthma.- GSK

    GlaxoSmithKline plc presented new data for Nucala (mepolizumab) from an interim analysis of REALITI-A , the first prospective global real-world...

    See more